Turtle Creek Wealth Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
Turtle Creek Wealth Advisors's BIIB Position: Q1 2026 in Review
Turtle Creek Wealth Advisors increased its Biogen (BIIB) stake by 5.7% in Q1 2026, buying an estimated $15.5K and bringing the position to 1,546 shares worth $283K. The position accounts for 0.02% of the portfolio, ranked #326.
Turtle Creek Wealth Advisors first reported a position in BIIB in Q4 2023 and has held it in 3 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Turtle Creek Wealth Advisors held 1,546 shares of Biogen worth $283K as of Q1 2026.
- Turtle Creek Wealth Advisors bought 84 Biogen shares in Q1 2026, an estimated $15.5K.
- Biogen made up 0.02% of Turtle Creek Wealth Advisors's portfolio in Q1 2026, its #326 holding.
- Turtle Creek Wealth Advisors first reported a position in Biogen in Q4 2023 and has held it in 3 quarters since.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Turtle Creek Wealth Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.